Abstract
Commentary: Cost-Effectiveness Analysis of Rivaroxaban Plus Aspirin Compared With Aspirin Alone in Patients With Coronary and Peripheral Artery Diseases in Italy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have